6.20 USD
↘ 0.31 (4.76%)AT CLOSE (11:59 AM EDT)
Niki BioSolutions, Inc. Common Stock
NIKINASDAQ • USD
6.47
↗ 0.27 (4.36%)
POST MARKET (AS OF 07:53 PM EDT)
Post Market
AS OF 07:53 PM EDT
6.47
↗ 0.27 (4.36%)
Market: CLOSED
Shares of Niki BioSolutions, Inc. Common Stock (NIKI) are trading at $6.20. The technical outlook is "Strong Sell" based on moving average alignment, RSI, and MACD signals. This is driven by a bearish Death Cross on the long-term moving averages.
Technical & fundamental data as of Sep 4, 2026.
Open?$7.15
High?$9.68
Low?$6.05
Prev. Close?$6.51
Volume?4.1M
Avg. Volume?N/A
VWAP?$8.42
Bid / Ask
Bid?$6.06 × 500
Ask?$6.50 × 800
Spread?$0.44
Midpoint?$6.28
Valuation & Ratios
Market Cap?5.0M
Shares Out?N/A
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Niki BioSolutions Inc, formerly Aptorum Group Ltd is a clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. Its project pipeline includes SACT-1, a repurposed drug for the treatment of neuroblastoma, and ALS-4, a small molecule for the treatment of bacterial infections caused by Staphylococcus aureus, including but not limited to Methicillin-resistant Staphylococcus aureus (MRSA).
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestLow
Short Interest?4.3K
Days to Cover?1.0
Avg Daily Volume27.1K
Settlement Date2026-08-14